These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8923077)

  • 21. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of sulfasalazine in rheumatic diseases.
    Fuchs HA
    Bull Rheum Dis; 1997 Nov; 46(7):3-4. PubMed ID: 9366125
    [No Abstract]   [Full Text] [Related]  

  • 23. Is the cure worse than the disease?
    Sacks R
    Aust Fam Physician; 2001 Jul; 30(7):679-80. PubMed ID: 11558203
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy].
    Keso L; Kaarela K; Oksanen K; Ahonen M
    Duodecim; 1998; 114(17):1731-3. PubMed ID: 11717780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
    Tamura N
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2873-9. PubMed ID: 23214096
    [No Abstract]   [Full Text] [Related]  

  • 26. Central-Variant Posterior Reversible Encephalopathy due to Sulfasalazine: A Case Report.
    Ocek L; Sener U; Demirtas BS; Ozcelik MM; Oztekin O; Zorlu Y
    Med Princ Pract; 2015; 24(6):578-80. PubMed ID: 26304730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfasalazine induced seizures and dysphasia.
    Hill ME; Gordon C; Situnayake RD; Heath DA
    J Rheumatol; 1994 Apr; 21(4):748-9. PubMed ID: 7913503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    van Rijthoven AW
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):539. PubMed ID: 10735141
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adverse effects of DMARDs in treatment of rheumatoid arthritis].
    Sugii S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():566-72. PubMed ID: 15799419
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of salazosulfapyridine induced hypersensitivity syndrome].
    Orita M; Katakura Y; Kobayashi M; Ishii T; Watanabe Y; Yotsuyanagi H; Suzuki M; Itoh F
    Nihon Shokakibyo Gakkai Zasshi; 2005 May; 102(5):600-4. PubMed ID: 15920959
    [No Abstract]   [Full Text] [Related]  

  • 31. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
    Gordon MM; Porter DR; Capell HA
    Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Kümmerle-Deschner J; Dannecker G
    Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
    Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
    Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migratory pulmonary infiltrates in a patient with rheumatoid arthritis.
    Mehandru S; Smith RL; Sidhu GS; Cassai N; Aranda CP
    Thorax; 2002 May; 57(5):465-7. PubMed ID: 11978928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
    Gunnarsson I; Nordmark B; Hassan Bakri A; Gröndal G; Larsson P; Forslid J; Klareskog L; Ringertz B
    Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.
    Taniguchi A; Urano W; Tanaka E; Furihata S; Kamitsuji S; Inoue E; Yamanaka M; Yamanaka H; Kamatani N
    Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
    Teraki Y; Izaki S
    Clin Exp Dermatol; 2009 Oct; 34(7):e287-8. PubMed ID: 19438549
    [No Abstract]   [Full Text] [Related]  

  • 38. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
    Schipper LG; Vermeer M; Kuper HH; Hoekstra MO; Haagsma CJ; Den Broeder AA; van Riel P; Fransen J; van de Laar MA
    Ann Rheum Dis; 2012 Jun; 71(6):845-50. PubMed ID: 22210852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration of left-ventricular diastolic dysfunction and pulmonary hypertension after TNF-alpha blocker.
    Korkmaz C; Kaşifoglu T; Yaşar B
    Ann Pharmacother; 2005 Jun; 39(6):1138-9. PubMed ID: 15870136
    [No Abstract]   [Full Text] [Related]  

  • 40. The Chinese herbal remedy Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis.
    Ann Intern Med; 2009 Aug; 151(4):I-36. PubMed ID: 19687475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.